Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Lozenge for Smokeless Tobacco Reduction
NCT00218283Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jan 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Started Jan 2005; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00218283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218283.